-
KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight
12 Nov 2025 18:00 GMT
… the KRAS inhibitors @ KRAS Inhibitors Analysis KRAS Inhibitors … Lung Cancer, Ovarian Cancer, Colorectal Cancer, and others
KRAS … KRAS Inhibitors Market Report
KRAS Inhibitors Therapeutic Assessment: KRAS … Cell Lung Cancer Market Non-small Cell Lung Cancer Market …
-
Max Healthcare oncologist says air pollution causes lung cancer, Delhi at high risk
04 Nov 2025 01:29 GMT
… between air pollution and lung cancer is no longer speculative; … number of respiratory and lung cancer cases during peak pollution … expansion of EGFR or KRAS mutant clones in the … adenocarcinoma, the most common lung cancer in never-smokers, particularly …
-
What Women Should Know About Lung Cancer
03 Nov 2025 02:25 GMT
… woman needs to know about lung cancer.
Lung Cancer Doesn’t Care How … for specific genetic mutations like KRAS, EGFR, and ALK.
Immunotherapy … Never Smoked | Lung Cancer | CDC
ACS Cancer Updates 2025 | Lung Cancer Initiative
Lung Cancer Screening Guidelines …
-
Studies identify complementary approaches to overcome drug resistance in KRAS G12C–mutant lung cancer
31 Oct 2025 12:01 GMT
… like non-small cell lung cancer, it can become stuck … mutations. According to the Lung Cancer Foundation of America, approximately … non-small cell lung cancer have a KRAS mutation, with the … Activation in Non-Small Cell Lung Cancer. Cancer Research. doi.org …
-
Moffitt Studies Uncover Complementary Strategies to Overcome Resistance to KRAS G12C Inhibitors in Lung Cancer
31 Oct 2025 05:24 GMT
… like non-small cell lung cancer, it can become stuck … mutations. According to the Lung Cancer Foundation of America, approximately … non-small cell lung cancer have a KRAS mutation, with the … Findings:
Tumors treated with KRAS G12C inhibitors often reactivate …
-
Moffitt Research Reveals Complementary Approaches to Combat Resistance to KRAS G12C Inhibitors in Lung Cancer
30 Oct 2025 21:15 GMT
… for lung cancer, researchers … ).
Keywords: Lung cancer, KRAS G12C mutation, … small cell lung cancer, therapeutic … lung cancer researchovercoming drug resistancepatient outcomes in lung cancertargeted therapies for NSCLCtherapeutic strategies for lung cancer
-
RMC-8839 shows promise for KRAS codon 13 mutant lung cancer
28 Oct 2025 20:20 GMT
-
Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
13 Nov 2025 21:01 GMT
… outcomes for patients with KRAS-mutant pancreatic cancer,” … targeting the most common KRAS mutations, which drive … indications including mKRAS positive lung cancer and other mKRAS … indications, including mKRAS positive lung cancer, other mKRAS positive …
-
ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
13 Nov 2025 21:10 GMT
… cancer and enozertinib in lung cancer. The ORIC-944 Phase … models, ORIC-944 plus KRAS inhibition improved efficacy and … or delaying resistance to KRAS inhibitors.
Enozertinib: a … mutant models, including intracranial lung cancer xenografts.
Continue to enroll …
-
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
22 Oct 2025 16:12 GMT
… patients with KRAS G12C non-small cell lung cancer (NSCLC) … Cancer Society. What is Lung Cancer. Available at: https:… Institute. Non-Small Cell Lung Cancer Treatment. Available at: https … Society. Key Statistics for Lung Cancer. Available at: https:…
About
© 1995-2025